News Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million…Louis LehotSeptember 27, 2023
News Foley Represents TCGX as a Lead Investor in $285M Financing for COMPASS Pathways Foley & Lardner LLP represented TCGX as a lead investor in the $285 million financing…Louis LehotSeptember 6, 2023
News Foley Represents TCGX as a Lead Investor in $200M Series C Financing for ADARx Foley & Lardner LLP represented TCGX as a lead investor in the oversubscribed $200 million…Louis LehotSeptember 6, 2023
Blogs Opportunity Zones: Should Your Startup Make One Its Home? Note: We'd like to thank Sarina Rogers, summer associate in the San Diego office, for…Alidad VakiliAugust 21, 2023
News Federico Goudie Discusses Latin American Startups’ Shift to Venture Debt Foley & Lardner LLP partner Federico Goudie is quoted in the Bloomberg article, “Latin American Startups Turn…Federico GoudieAugust 21, 2023
News Foley Represents Cortical Ventures in Pre-Seed Round for Kyber Labs Foley & Lardner LLP recently represented Cortical Ventures as an investor in a pre-seed funding…Saige GallopAugust 17, 2023
Blogs Webinar Key takeaways: Early-Stage Start-up Financings in 2023 Foley recently cohosted a webinar with 4thly where a panel of experts discussed early-stage start-up…Louis LehotJune 15, 2023
Events Implications of the SVB Collapse for All Board Members March 15, 2023 | 12:00 p.m. PT When the dust settles from the collapse of…Louis LehotMarch 14, 2023
News Foley Represents TCGX in Second Investment in Abivax Foley & Lardner LLP represented TCG Crossover (TCGX) as the lead investor in the successful,…Louis LehotFebruary 27, 2023
Blogs Singapore: A Rising Tiger Economy for Startups and Venture Capital in Asia As we project ourselves forward in 2023, amidst the clouds, a bright spot for optimism…Louis LehotJanuary 30, 2023